A leading group of UK cancer experts has welcomed the announcement by Cancer Research UK that brain tumours will be a focus of their new strategy for the next five years.
The British Neuro-Oncology Society (BNOS) says this new drive for a vitally-needed boost in funds for research could dramatically change the landscape for patients with brain cancer and their families.
President of BNOS, Professor David Walker commented stating that “we cannot be more delighted that CRUK have announced that brain and spinal tumours will be one of the four big ‘hard to treat’ cancers to be the focus of increased research and funding. This development builds upon the successful strategy of a number of patient and family-based, as well as academic charity research initiatives which have been active over the past couple of decades.”
He also added that “CRUK’s announcement is most welcome as they are the biggest funder of cancer research in Europe and so can bring substantial resources and cancer expertise to bear upon this subject.”
Brain tumours are the biggest cancer killer of people under 40 years of age but historically the disease has only attracted around 2% of funding for research into faster diagnosis and new treatments.